Fig. 5From: Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patientsFunnel plot of primary outcomes for evaluation of publication bias. Secondary outcomes were not analyzed because of low number of studies included. A Mortality, B Progression to severe disease, C Negative RT-PCRBack to article page